| Sarcomatoid Carcinoma studied in …STUDIED_INderived10 of 37show all (up to 200) |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07005297not yet recruiting Clinical Genetics Branch Eligibility Screening Survey · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Pulmonary Blastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02734537Phase 2 · recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Laryngeal Spindle Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ALIAS · 37 trials mapped (22 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06568172Phase 3 · suspended Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer · condition mapped CURATED_BROADER · 37 trials mapped (22 active) | — | — | Skin Spindle Cell Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793166Phase 3 · active not recruiting Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03055013Phase 3 · active not recruiting Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06866262Phase 1/Phase 2 · recruiting Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial · condition mapped CURATED_BROADER · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06049576Phase 1 · active not recruiting Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 37 trials mapped (22 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |